ArticleLeukemia & lymphoma2009

Genetic polymorphism of the inhibitory IgG Fc receptor FcgammaRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab.

Wen-Kai Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.